A detailed history of Corton Capital Inc. transactions in Maravai Lifesciences Holdings, Inc. stock. As of the latest transaction made, Corton Capital Inc. holds 36,468 shares of MRVI stock, worth $194,374. This represents 0.15% of its overall portfolio holdings.

Number of Shares
36,468
Previous 13,869 162.95%
Holding current value
$194,374
Previous $99,000 206.06%
% of portfolio
0.15%
Previous 0.05%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$6.84 - $9.73 $154,577 - $219,888
22,599 Added 162.95%
36,468 $303,000
Q2 2024

Aug 14, 2024

BUY
$6.87 - $11.34 $95,280 - $157,274
13,869 New
13,869 $99,000
Q2 2022

Aug 15, 2022

SELL
$26.05 - $37.48 $267,325 - $384,619
-10,262 Closed
0 $0
Q1 2022

May 16, 2022

SELL
$24.46 - $40.92 $30,917 - $51,722
-1,264 Reduced 10.97%
10,262 $362,000
Q4 2021

Feb 14, 2022

BUY
$35.0 - $45.94 $403,410 - $529,504
11,526 New
11,526 $483,000

Others Institutions Holding MRVI

About MARAVAI LIFESCIENCES HOLDINGS, INC.


  • Ticker MRVI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 131,540,000
  • Market Cap $701M
  • Description
  • Maravai LifeSciences Holdings, Inc., a life sciences company, provides products to enable the development of drug therapies, diagnostics, novel vaccines, and support research on human diseases in the United States and internationally. The company's products address the key phases of biopharmaceutical development and include nucleic acids for dia...
More about MRVI
Track This Portfolio

Track Corton Capital Inc. Portfolio

Follow Corton Capital Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Corton Capital Inc., based on Form 13F filings with the SEC.

News

Stay updated on Corton Capital Inc. with notifications on news.